Rifamycin Antimycobacterial [EPC]

Rifamycin Antimycobacterial [EPC] was reported 3496 times

Drugs of the Rifamycin Antimycobacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 RETICULOCYTE HAEMOGLOBIN DECREASED 2 0.2857
1 AIDS CHOLANGIOPATHY 2 0.1667
2 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 34 0.1538
3 HIV WASTING SYNDROME 5 0.1389
4 ATYPICAL MYCOBACTERIAL LYMPHADENITIS 5 0.1163
5 BRONCHIAL ARTERY EMBOLISATION 2 0.1053
6 MINIMUM INHIBITORY CONCENTRATION INCREASED 2 0.1000
7 ATYPICAL MYCOBACTERIAL LOWER RESPIRATORY TRACT INFECTION 6 0.0833
8 GYNAECOLOGICAL CHLAMYDIA INFECTION 4 0.0755
9 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 25 0.0746
10 INCOMPLETE SPINAL FUSION 2 0.0714
11 MYCOBACTERIUM HAEMOPHILUM INFECTION 17 0.0594
12 MYCOBACTERIUM AVIUM COMPLEX INFECTION 151 0.0562
13 ACID FAST BACILLI INFECTION 9 0.0559
14 AIDS ENCEPHALOPATHY 3 0.0517
15 NECROTISING GRANULOMATOUS LYMPHADENITIS 2 0.0465
16 ATYPICAL MYCOBACTERIAL PNEUMONIA 6 0.0432
17 ANTICOAGULATION DRUG LEVEL DECREASED 5 0.0413
18 ATYPICAL MYCOBACTERIUM TEST POSITIVE 4 0.0412
19 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 11 0.0406
20 IMMUNE RECOVERY UVEITIS 2 0.0345
21 PULMONARY HILUM MASS 6 0.0319
22 COLOUR VISION TESTS ABNORMAL 2 0.0303
23 RHODOCOCCUS INFECTION 5 0.0301
24 MYCOBACTERIAL INFECTION 50 0.0290
25 ATYPICAL MYCOBACTERIAL INFECTION 41 0.0290
26 LEISHMANIASIS 8 0.0276
27 FEMORAL ARTERY ANEURYSM 3 0.0273
28 NICOTINIC ACID DEFICIENCY 3 0.0270
29 NECROTISING HERPETIC RETINOPATHY 2 0.0270
30 IMMUNE RECONSTITUTION SYNDROME 31 0.0240
31 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 119 0.0239
32 MESENTERIC PANNICULITIS 7 0.0234
33 MYCOBACTERIUM MARINUM INFECTION 7 0.0215
34 KIDNEY RUPTURE 4 0.0215
35 MULTIPLE DRUG HYPERSENSITIVITY 2 0.0208
36 HYPOPYON 17 0.0205
37 DIALYSIS HYPOTENSION 2 0.0202
38 LEUKOERYTHROBLASTOSIS 2 0.0200
39 MYCOBACTERIUM TEST POSITIVE 4 0.0194
40 DOSING ERROR 3 0.0179
41 INTESTINAL MUCOSAL HYPERTROPHY 3 0.0164
42 PERIPORTAL OEDEMA 2 0.0160
43 MEDIASTINAL MASS 6 0.0157
44 MYCOBACTERIUM ABSCESSUS INFECTION 11 0.0154
45 CELL-MEDIATED IMMUNE DEFICIENCY 2 0.0143
46 CHYLOTHORAX 10 0.0139
47 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 5 0.0138
48 BACTERIAL ABDOMINAL INFECTION 2 0.0136
49 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 16 0.0133
50 BRUCELLOSIS 2 0.0132
51 OTOTOXICITY 24 0.0130
52 SALMONELLA SEPSIS 3 0.0125
53 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 11 0.0124
54 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 5 0.0123
55 CYTOMEGALOVIRUS CHORIORETINITIS 24 0.0123
56 CEREBRAL CONGESTION 2 0.0119
57 CEREBRAL TOXOPLASMOSIS 11 0.0118
58 INTESTINAL TUBERCULOSIS 2 0.0115
59 MICROSPORIDIA INFECTION 4 0.0114
60 CEREBRAL CALCIFICATION 3 0.0112
61 CUTANEOUS TUBERCULOSIS 2 0.0110
62 MYCOBACTERIUM CHELONAE INFECTION 8 0.0108
63 CORNEAL DEPOSITS 8 0.0108
64 REPETITIVE SPEECH 6 0.0107
65 BRONCHOPLEURAL FISTULA 4 0.0106
66 PULMONARY CAVITATION 9 0.0103
67 HILAR LYMPHADENOPATHY 9 0.0102
68 KAPOSI'S SARCOMA 5 0.0100
69 HYPOCHROMASIA 2 0.0100
70 PNEUMOCYSTIS CARINII PNEUMONIA 2 0.0099
71 GASTROENTERITIS CRYPTOSPORIDIAL 2 0.0099
72 DISSEMINATED TUBERCULOSIS 25 0.0097
73 MICROTIA 3 0.0095
74 CRYSTAL ARTHROPATHY 2 0.0095
75 TUBERCULOSIS GASTROINTESTINAL 3 0.0094
76 TOXIC OPTIC NEUROPATHY 4 0.0092
77 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 6 0.0090
78 CAROTID ARTERY ANEURYSM 3 0.0088
79 OPTIC DISC HAEMORRHAGE 2 0.0087
80 IRIDOCYCLITIS 27 0.0085
81 KIDNEY MALFORMATION 3 0.0085
82 PLASMABLASTIC LYMPHOMA 3 0.0084
83 ABDOMINAL LYMPHADENOPATHY 7 0.0081
84 LYMPH NODE TUBERCULOSIS 6 0.0081
85 MICROCYTOSIS 2 0.0081
86 DEAFNESS NEUROSENSORY 26 0.0079
87 CHEST WALL MASS 2 0.0077
88 DEPOSIT EYE 2 0.0075
89 POIKILOCYTOSIS 2 0.0072
90 PERITONEAL TUBERCULOSIS 3 0.0068
91 ALVEOLAR PROTEINOSIS 4 0.0068
92 POLYCHROMASIA 2 0.0067
93 LYMPHADENITIS 16 0.0066
94 DRUG RESISTANCE 165 0.0064
95 CHRONIC HEPATITIS B 2 0.0063
96 INTRA-ABDOMINAL HAEMORRHAGE 15 0.0063
97 ASPERGILLOMA 2 0.0063
98 OPTIC NEUROPATHY 13 0.0061
99 CRYPTOCOCCOSIS 10 0.0061
100 MULTIPLE-DRUG RESISTANCE 19 0.0061
101 DEAFNESS BILATERAL 10 0.0059
102 LYMPHADENOPATHY MEDIASTINAL 11 0.0057
103 ANION GAP DECREASED 2 0.0057
104 DRUG LEVEL ABNORMAL 3 0.0056
105 COMPLICATIONS OF TRANSPLANTED LIVER 2 0.0056
106 GLOMERULONEPHRITIS PROLIFERATIVE 2 0.0055
107 ABSCESS BACTERIAL 2 0.0055
108 CYTOMEGALOVIRUS OESOPHAGITIS 2 0.0054
109 OCULAR TOXICITY 6 0.0054
110 IDIOSYNCRATIC DRUG REACTION 5 0.0051
111 EXTRADURAL ABSCESS 4 0.0051
112 SPUTUM RETENTION 5 0.0050
113 GROWTH HORMONE DEFICIENCY 2 0.0050
114 BLOOD HIV RNA INCREASED 9 0.0050
115 SPUTUM CULTURE POSITIVE 4 0.0049
116 PULMONARY TUBERCULOSIS 21 0.0049
117 OPEN ANGLE GLAUCOMA 3 0.0049
118 HYPERTRANSAMINASAEMIA 34 0.0049
119 OESOPHAGEAL ATRESIA 3 0.0048
120 PARADOXICAL DRUG REACTION 17 0.0046
121 BRONCHIECTASIS 31 0.0046
122 UVEITIS 62 0.0046
123 JOINT DESTRUCTION 7 0.0045
124 PATHOGEN RESISTANCE 41 0.0045
125 THERAPEUTIC PRODUCT CROSS-REACTIVITY 4 0.0045
126 HEPATIC ENZYME DECREASED 2 0.0045
127 DRUG LEVEL DECREASED 44 0.0043
128 URINARY TRACT INFECTION ENTEROCOCCAL 4 0.0043
129 CRANIAL NERVE PARALYSIS 2 0.0042
130 HEPATITIS TOXIC 11 0.0042
131 VASCULITIS NECROTISING 3 0.0042
132 CHRONIC RESPIRATORY FAILURE 5 0.0041
133 LYMPHADENECTOMY 4 0.0041
134 NOSOCOMIAL INFECTION 9 0.0041
135 ENCEPHALITIS HERPES 2 0.0040
136 VITAMIN B COMPLEX DEFICIENCY 3 0.0040
137 INFECTIVE ANEURYSM 2 0.0040
138 PERSECUTORY DELUSION 10 0.0040
139 INFUSION SITE VESICLES 2 0.0038
140 VITRITIS 7 0.0038
141 DYSCHROMATOPSIA 3 0.0036
142 MENINGITIS TUBERCULOUS 2 0.0036
143 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 90 0.0035
144 HEPATITIS CHOLESTATIC 21 0.0035
145 POLYDACTYLY 4 0.0034
146 PERIPHERAL NERVE INJURY 3 0.0034
147 PROCALCITONIN INCREASED 4 0.0034
148 VARICELLA ZOSTER VIRUS INFECTION 7 0.0034
149 LIVER TRANSPLANT REJECTION 6 0.0033
150 ABSCESS LIMB 14 0.0033
151 BLOOD BILIRUBIN DECREASED 2 0.0032
152 SPUTUM INCREASED 7 0.0032
153 GRANULOMA 11 0.0032
154 HEPATOTOXICITY 70 0.0031
155 INCREASED VISCOSITY OF BRONCHIAL SECRETION 2 0.0031
156 ILEOSTOMY 8 0.0031
157 BRONCHOPULMONARY ASPERGILLOSIS 24 0.0031
158 CROSS SENSITIVITY REACTION 3 0.0031
159 DUST ALLERGY 3 0.0031
160 HEMIANOPIA 3 0.0030
161 BILIRUBIN CONJUGATED INCREASED 7 0.0030
162 HYPERBILIRUBINAEMIA 31 0.0030
163 TRANSPLANT REJECTION 23 0.0029
164 RETROPERITONEAL HAEMORRHAGE 7 0.0028
165 JARISCH-HERXHEIMER REACTION 2 0.0028
166 MENINGITIS BACTERIAL 4 0.0028
167 OCULAR ICTERUS 12 0.0028
168 HODGKIN'S DISEASE 2 0.0028
169 BLOOD FOLATE DECREASED 2 0.0028
170 FOOT AMPUTATION 4 0.0027
171 ASPERGILLUS INFECTION 18 0.0027
172 DRUG LEVEL BELOW THERAPEUTIC 15 0.0027
173 GASTRITIS HAEMORRHAGIC 4 0.0027
174 CHLAMYDIAL INFECTION 2 0.0026
175 BASOPHIL COUNT INCREASED 2 0.0026
176 PULMONARY GRANULOMA 3 0.0026
177 INFECTION REACTIVATION 3 0.0026
178 CONVERSION DISORDER 5 0.0026
179 ACUTE HEPATIC FAILURE 35 0.0026
180 FUNGAEMIA 4 0.0025
181 PNEUMONIA INFLUENZAL 3 0.0025
182 OESOPHAGEAL CANDIDIASIS 10 0.0025
183 SUBCUTANEOUS ABSCESS 12 0.0025
184 ENTEROCOCCAL SEPSIS 2 0.0025
185 MONOCYTE COUNT DECREASED 3 0.0025
186 BLOOD ELECTROLYTES ABNORMAL 3 0.0024
187 ANAEMIA HAEMOLYTIC AUTOIMMUNE 2 0.0024
188 NEPHROPATHY TOXIC 27 0.0024
189 LATENT TUBERCULOSIS 5 0.0024
190 CONTRAINDICATED PRODUCT PRESCRIBED 4 0.0024
191 TOOTH DISCOLOURATION 7 0.0024
192 MIXED LIVER INJURY 7 0.0023
193 FIXED ERUPTION 4 0.0023
194 ELECTROCARDIOGRAM T WAVE INVERSION 5 0.0023
195 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 20 0.0023
196 PNEUMOCYSTIS JIROVECI PNEUMONIA 5 0.0022
197 VOCAL CORD PARALYSIS 4 0.0022
198 ANAEMIA OF CHRONIC DISEASE 2 0.0022
199 COMPLICATIONS OF TRANSPLANTED KIDNEY 5 0.0022
200 CORNEAL OPACITY 3 0.0022
201 RASH MORBILLIFORM 6 0.0022
202 LICHEN PLANUS 5 0.0022
203 ARTHRITIS INFECTIVE 10 0.0022
204 H1N1 INFLUENZA 3 0.0021
205 DRUG INTERACTION 337 0.0021
206 INTERVERTEBRAL DISCITIS 4 0.0021
207 HYPOPROTEINAEMIA 4 0.0021
208 EOSINOPHIL COUNT DECREASED 5 0.0021
209 NEPHRITIS 7 0.0021
210 PYELOCALIECTASIS 2 0.0021
211 PNEUMONIA CYTOMEGALOVIRAL 4 0.0021
212 LYMPHOPENIA 29 0.0020
213 RENAL TRANSPLANT FAILURE 2 0.0020
214 HYPOCHROMIC ANAEMIA 2 0.0020
215 PNEUMONIA PSEUDOMONAL 3 0.0020
216 CALCULUS URINARY 3 0.0019
217 TRANSCRIPTION MEDICATION ERROR 3 0.0019
218 LUNG ABSCESS 4 0.0019
219 PSEUDOMEMBRANOUS COLITIS 4 0.0018
220 SUSPECTED OFF LABEL USE 8 0.0018
221 BLOOD FIBRINOGEN DECREASED 2 0.0018
222 CACHEXIA 9 0.0017
223 PULMONARY MASS 26 0.0017
224 PO2 DECREASED 2 0.0017
225 ENTEROCOLITIS 10 0.0017
226 PRURITUS ALLERGIC 2 0.0017
227 LIP ULCERATION 2 0.0017
228 FANCONI SYNDROME ACQUIRED 3 0.0017
229 HYPERURICAEMIA 7 0.0017
230 VIROLOGIC FAILURE 9 0.0017
231 HIV INFECTION 5 0.0017
232 OESOPHAGEAL SPASM 3 0.0016
233 EOSINOPHILIC PNEUMONIA 5 0.0016
234 DEAFNESS 41 0.0016
235 HEPATIC INFECTION 2 0.0016
236 ELECTROCARDIOGRAM QT PROLONGED 56 0.0016
237 OPTIC NEURITIS 14 0.0015
238 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
239 MALNUTRITION 17 0.0015
240 LEUKOPENIA 75 0.0015
241 DRUG-INDUCED LIVER INJURY 47 0.0015
242 IMMUNOSUPPRESSION 13 0.0015
243 CARBON DIOXIDE INCREASED 2 0.0015
244 ARTHRITIS BACTERIAL 6 0.0015
245 HYPOSPADIAS 3 0.0014
246 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0014
247 RENAL TUBULAR DISORDER 4 0.0014
248 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 3 0.0014
249 ENTERITIS 9 0.0014
250 CD4 LYMPHOCYTES DECREASED 3 0.0014
251 DRUG INTOLERANCE 135 0.0014
252 VITREOUS DETACHMENT 3 0.0014
253 LABELLED DRUG-DRUG INTERACTION ISSUE 2 0.0014
254 RENAL TUBULAR ACIDOSIS 3 0.0014
255 HENOCH-SCHONLEIN PURPURA 3 0.0014
256 DYSPHEMIA 6 0.0014
257 NORMOCYTIC ANAEMIA 2 0.0014
258 VIRAL MUTATION IDENTIFIED 5 0.0014
259 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
260 RENAL TUBULAR NECROSIS 13 0.0013
261 TREATMENT FAILURE 109 0.0013
262 CYTOPENIA 16 0.0013
263 PANCYTOPENIA 73 0.0013
264 MEAN CELL VOLUME DECREASED 2 0.0013
265 METHAEMOGLOBINAEMIA 3 0.0013
266 HAEMOPTYSIS 36 0.0013
267 PULMONARY FUNCTION TEST ABNORMAL 2 0.0013
268 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 3 0.0013
269 PNEUMONIA FUNGAL 5 0.0013
270 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 3 0.0013
271 HEPATIC CYTOLYSIS 16 0.0013
272 PNEUMONIA LEGIONELLA 2 0.0012
273 CUSHINGOID 4 0.0012
274 OPTIC ATROPHY 2 0.0012
275 HEPATOMEGALY 12 0.0012
276 OXYGEN THERAPY 2 0.0012
277 HYPERCALCAEMIA 15 0.0012
278 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 2 0.0012
279 CHROMATURIA 27 0.0012
280 POTENTIATING DRUG INTERACTION 4 0.0012
281 BRAIN ABSCESS 3 0.0012
282 HEPATOSPLENOMEGALY 3 0.0012
283 BLOOD CHLORIDE DECREASED 3 0.0012
284 LUNG OPACITY 3 0.0011
285 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
286 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
287 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 6 0.0011
288 HYDROCEPHALUS 6 0.0011
289 CHOLESTASIS 21 0.0011
290 MEAN CELL HAEMOGLOBIN DECREASED 2 0.0011
291 IMMUNE THROMBOCYTOPENIA 5 0.0011
292 PNEUMONIA BACTERIAL 10 0.0011
293 DISORGANISED SPEECH 2 0.0011
294 RASH MACULO-PAPULAR 24 0.0011
295 BLOOD BICARBONATE DECREASED 2 0.0011
296 OESOPHAGEAL ULCER 4 0.0010
297 HAEMOLYSIS 8 0.0010
298 ENTEROCOCCAL INFECTION 5 0.0010
299 ADENOVIRUS INFECTION 3 0.0010
300 RASH VESICULAR 5 0.0010
301 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
302 CONCOMITANT DISEASE PROGRESSION 2 0.0010
303 HEPATITIS FULMINANT 3 0.0010
304 GENE MUTATION 2 0.0010
305 EMPYEMA 2 0.0010
306 BRAIN HERNIATION 3 0.0010
307 ATYPICAL PNEUMONIA 3 0.0010
308 BLOOD CULTURE POSITIVE 3 0.0010
309 DERMATITIS EXFOLIATIVE 5 0.0010
310 HYPERCAPNIA 3 0.0010
311 PANIC REACTION 7 0.0010
312 VISUAL FIELD DEFECT 7 0.0010
313 DRUG LEVEL INCREASED 16 0.0010
314 FAILURE TO THRIVE 5 0.0010
315 CONGESTIVE CARDIOMYOPATHY 4 0.0010
316 DRUG ERUPTION 17 0.0010
317 TRANSAMINASES INCREASED 21 0.0009
318 BONE MARROW FAILURE 19 0.0009
319 LIVER FUNCTION TEST INCREASED 20 0.0009
320 HYPERPHOSPHATAEMIA 2 0.0009
321 LYMPHOCYTOSIS 2 0.0009
322 ABSCESS INTESTINAL 2 0.0009
323 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0009
324 HEPATITIS ACUTE 6 0.0009
325 NEUTROPENIA 124 0.0009
326 ADRENAL INSUFFICIENCY 11 0.0009
327 HYPERTENSIVE CRISIS 10 0.0009
328 HEPATITIS 23 0.0009
329 NECROSIS 5 0.0009
330 CHOLESTATIC LIVER INJURY 2 0.0009
331 BACTERIAL TEST POSITIVE 2 0.0009
332 TORSADE DE POINTES 7 0.0009
333 EAR DISCOMFORT 9 0.0009
334 PRODUCT PRESCRIBING ISSUE 19 0.0009
335 SHOCK 20 0.0009
336 YELLOW SKIN 4 0.0009
337 DEPRESSIVE SYMPTOM 3 0.0009
338 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 7 0.0008
339 GLOSSITIS 3 0.0008
340 LONG QT SYNDROME 2 0.0008
341 SARS-COV-2 TEST POSITIVE 11 0.0008
342 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
343 HEPATIC FUNCTION ABNORMAL 31 0.0008
344 PANNICULITIS 2 0.0008
345 FOOD INTOLERANCE 3 0.0008
346 VITREOUS FLOATERS 8 0.0008
347 MYELOSUPPRESSION 29 0.0008
348 EOSINOPHILIA 14 0.0008
349 PLATELET DISORDER 2 0.0008
350 KLEBSIELLA INFECTION 4 0.0008
351 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
352 ANOREXIA 10 0.0008
353 OSTEOMYELITIS 14 0.0008
354 VIRAL LOAD INCREASED 3 0.0008
355 BRONCHOSPASM 11 0.0008
356 RETINAL DISORDER 2 0.0008
357 HYPERSENSITIVITY VASCULITIS 2 0.0008
358 ORAL CANDIDIASIS 10 0.0008
359 BLOOD ALBUMIN DECREASED 6 0.0008
360 CARDIAC FAILURE ACUTE 5 0.0007
361 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
362 CANDIDIASIS 3 0.0007
363 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 41 0.0007
364 HYPERLACTACIDAEMIA 2 0.0007
365 ORGAN FAILURE 3 0.0007
366 JAUNDICE 20 0.0007
367 SPUTUM DISCOLOURED 7 0.0007
368 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
369 HICCUPS 6 0.0007
370 MACULE 2 0.0007
371 SECRETION DISCHARGE 9 0.0007
372 THROMBOCYTOPENIA 80 0.0007
373 LUNG CONSOLIDATION 2 0.0007
374 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2 0.0007
375 IMMUNE THROMBOCYTOPENIC PURPURA 2 0.0007
376 LYMPHADENOPATHY 25 0.0007
377 RESPIRATORY SYMPTOM 2 0.0007
378 OESOPHAGEAL STENOSIS 2 0.0007
379 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
380 LIP PAIN 2 0.0007
381 PNEUMOTHORAX 11 0.0007
382 PARAPLEGIA 2 0.0007
383 PYREXIA 237 0.0007
384 HELICOBACTER INFECTION 7 0.0007
385 ABDOMINAL ABSCESS 3 0.0007
386 PURPURA 6 0.0007
387 HYPOPHOSPHATAEMIA 5 0.0007
388 CREPITATIONS 2 0.0007
389 ODYNOPHAGIA 4 0.0007
390 HAEMOLYTIC ANAEMIA 6 0.0007
391 HYPERLIPIDAEMIA 8 0.0007
392 SINUS CONGESTION 9 0.0007
393 NEUROPATHY PERIPHERAL 63 0.0007
394 BONE MARROW DISORDER 2 0.0007
395 LUPUS-LIKE SYNDROME 6 0.0007
396 EMERGENCY CARE 2 0.0007
397 IRON DEFICIENCY ANAEMIA 6 0.0006
398 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
399 ASCITES 19 0.0006
400 PERSONALITY CHANGE 6 0.0006
401 BLOOD CREATININE DECREASED 2 0.0006
402 PNEUMONIA VIRAL 2 0.0006
403 KIDNEY TRANSPLANT REJECTION 3 0.0006
404 ACUTE RESPIRATORY FAILURE 12 0.0006
405 LYMPHOCYTE COUNT DECREASED 11 0.0006
406 ASPARTATE AMINOTRANSFERASE INCREASED 33 0.0006
407 NIGHT SWEATS 20 0.0006
408 ALANINE AMINOTRANSFERASE INCREASED 38 0.0006
409 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0006
410 HERPES SIMPLEX 4 0.0006
411 PHARYNGEAL SWELLING 6 0.0006
412 TINNITUS 28 0.0006
413 PANCREATIC DISORDER 3 0.0006
414 HYPERVOLAEMIA 3 0.0006
415 LISTLESS 2 0.0006
416 BLOOD ALKALINE PHOSPHATASE INCREASED 15 0.0006
417 MULTIPLE ORGAN DYSFUNCTION SYNDROME 17 0.0006
418 EOSINOPHIL COUNT INCREASED 5 0.0006
419 LYME DISEASE 2 0.0006
420 MENINGITIS 4 0.0006
421 HYPERKALAEMIA 21 0.0006
422 SPLENOMEGALY 7 0.0006
423 EMPHYSEMA 6 0.0006
424 BACTERIAL INFECTION 11 0.0006
425 PRODUCTIVE COUGH 28 0.0006
426 DEVICE RELATED INFECTION 9 0.0006
427 BLOOD CREATININE ABNORMAL 2 0.0006
428 DEPRESSION SUICIDAL 2 0.0006
429 ACUTE KIDNEY INJURY 88 0.0006
430 PETECHIAE 6 0.0006
431 MALABSORPTION 3 0.0006
432 RIGHT VENTRICULAR FAILURE 4 0.0006
433 BLOOD LACTIC ACID INCREASED 3 0.0006
434 GASTROINTESTINAL DISORDER 51 0.0006
435 SERUM FERRITIN INCREASED 3 0.0006
436 DISEASE RECURRENCE 27 0.0006
437 RENAL FAILURE ACUTE 24 0.0006
438 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
439 BONE LESION 2 0.0006
440 TREATMENT NONCOMPLIANCE 30 0.0005
441 CUTANEOUS VASCULITIS 2 0.0005
442 DELIRIUM 19 0.0005
443 PHOTOSENSITIVITY REACTION 9 0.0005
444 INTESTINAL ISCHAEMIA 3 0.0005
445 CYSTIC FIBROSIS 3 0.0005
446 HIATUS HERNIA 7 0.0005
447 CARDIAC DYSFUNCTION 2 0.0005
448 LUNG DISORDER 26 0.0005
449 PARANASAL SINUS HYPERSECRETION 2 0.0005
450 VENTRICULAR SEPTAL DEFECT 3 0.0005
451 RENAL IMPAIRMENT 44 0.0005
452 INFLUENZA LIKE ILLNESS 43 0.0005
453 OESOPHAGEAL DISORDER 2 0.0005
454 LYMPHOMA 8 0.0005
455 HEPATIC ENZYME INCREASED 35 0.0005
456 PRODUCT USE IN UNAPPROVED INDICATION 126 0.0005
457 BACTERAEMIA 6 0.0005
458 PROTHROMBIN TIME PROLONGED 3 0.0005
459 HEPATITIS B 3 0.0005
460 NEUTROPHIL COUNT INCREASED 5 0.0005
461 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
462 ILEUS 6 0.0005
463 BLOOD BILIRUBIN INCREASED 13 0.0005
464 PERICARDIAL EFFUSION 11 0.0005
465 HALLUCINATION, VISUAL 10 0.0005
466 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
467 PURULENT DISCHARGE 2 0.0005
468 PSEUDOMONAS INFECTION 4 0.0005
469 INCOHERENT 3 0.0005
470 ECONOMIC PROBLEM 7 0.0005
471 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
472 MELANOCYTIC NAEVUS 2 0.0005
473 GASTRITIS 12 0.0005
474 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
475 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
476 STEVENS-JOHNSON SYNDROME 10 0.0004
477 LIVER INJURY 11 0.0004
478 THERAPY INTERRUPTED 32 0.0004
479 SKIN INFECTION 5 0.0004
480 BLOOD CALCIUM DECREASED 5 0.0004
481 HALLUCINATION, AUDITORY 7 0.0004
482 SEPTIC SHOCK 19 0.0004
483 ENCEPHALITIS 3 0.0004
484 AGRANULOCYTOSIS 8 0.0004
485 APHONIA 6 0.0004
486 GASTRITIS EROSIVE 2 0.0004
487 BLOOD CREATININE INCREASED 28 0.0004
488 HEPATIC ENCEPHALOPATHY 4 0.0004
489 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
490 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
491 ANHEDONIA 11 0.0004
492 CHILLS 49 0.0004
493 HYPOVOLAEMIC SHOCK 2 0.0004
494 HEPATITIS C 5 0.0004
495 DISEASE PROGRESSION 49 0.0004
496 RASH PUSTULAR 3 0.0004
497 ORTHOSTATIC HYPOTENSION 7 0.0004
498 ANEURYSM 2 0.0004
499 SKIN LESION 11 0.0004
500 PANCREATITIS ACUTE 9 0.0004
501 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
502 RESPIRATORY FAILURE 29 0.0004
503 TENDON PAIN 3 0.0004
504 HAEMODYNAMIC INSTABILITY 3 0.0004
505 ACIDOSIS 3 0.0004
506 MYALGIA 66 0.0004
507 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
508 LEUKOCYTOSIS 7 0.0004
509 APHTHOUS ULCER 3 0.0004
510 EXPOSURE DURING PREGNANCY 24 0.0004
511 PELVIC FRACTURE 3 0.0004
512 TENDERNESS 4 0.0004
513 ANAEMIA 73 0.0004
514 BEDRIDDEN 5 0.0004
515 TRICUSPID VALVE INCOMPETENCE 3 0.0004
516 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
517 ABSCESS 6 0.0004
518 TOXICITY TO VARIOUS AGENTS 63 0.0004
519 RENAL FAILURE 49 0.0004
520 OESOPHAGITIS 4 0.0004
521 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
522 CYTOMEGALOVIRUS INFECTION 6 0.0004
523 VENTRICULAR FIBRILLATION 4 0.0004
524 MENTAL STATUS CHANGES 10 0.0004
525 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
526 INTRACRANIAL PRESSURE INCREASED 2 0.0004
527 ATRIAL SEPTAL DEFECT 3 0.0004
528 HAEMODIALYSIS 3 0.0004
529 SENSATION OF FOREIGN BODY 3 0.0004
530 CANDIDA INFECTION 6 0.0004
531 REBOUND EFFECT 4 0.0004
532 SEASONAL ALLERGY 5 0.0004
533 DECREASED APPETITE 82 0.0004
534 CHOLECYSTITIS ACUTE 2 0.0004
535 HEPATOCELLULAR INJURY 5 0.0004
536 GRANULOCYTOPENIA 2 0.0004
537 HAEMATURIA 12 0.0004
538 FULL BLOOD COUNT DECREASED 7 0.0003
539 DYSPNOEA EXERTIONAL 13 0.0003
540 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
541 LIVER FUNCTION TEST ABNORMAL 10 0.0003
542 BODY TEMPERATURE INCREASED 7 0.0003
543 HYPOVOLAEMIA 2 0.0003
544 WHITE BLOOD CELL COUNT DECREASED 37 0.0003
545 LACTIC ACIDOSIS 11 0.0003
546 LUNG INFILTRATION 3 0.0003
547 URINARY INCONTINENCE 10 0.0003
548 WEIGHT DECREASED 94 0.0003
549 THERAPY NON-RESPONDER 15 0.0003
550 ENDOPHTHALMITIS 2 0.0003
551 PLEURAL EFFUSION 20 0.0003
552 INSURANCE ISSUE 5 0.0003
553 RESPIRATORY DISTRESS 9 0.0003
554 HYPOKALAEMIA 15 0.0003
555 GRAND MAL CONVULSION 3 0.0003
556 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
557 TENDONITIS 5 0.0003
558 CHOLANGITIS 2 0.0003
559 ERYTHEMA MULTIFORME 3 0.0003
560 NEPHROPATHY 3 0.0003
561 COUGH 90 0.0003
562 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
563 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
564 VOMITING 150 0.0003
565 CYANOSIS 5 0.0003
566 PHOTOPSIA 2 0.0003
567 MUSCLE ATROPHY 4 0.0003
568 LIVER DISORDER 14 0.0003
569 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
570 CONDITION AGGRAVATED 95 0.0003
571 NODULE 4 0.0003
572 NAUSEA 241 0.0003
573 HYPOGAMMAGLOBULINAEMIA 2 0.0003
574 RENAL INJURY 9 0.0003
575 RASH 132 0.0003
576 OFF LABEL USE 265 0.0003
577 APPETITE DISORDER 2 0.0003
578 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
579 BLOOD UREA INCREASED 5 0.0003
580 TOXIC SKIN ERUPTION 3 0.0003
581 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
582 TASTE DISORDER 6 0.0003
583 BLINDNESS 12 0.0003
584 TACHYPNOEA 4 0.0003
585 CHEST DISCOMFORT 30 0.0003
586 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
587 NEPHROTIC SYNDROME 2 0.0003
588 OSTEOPOROSIS 12 0.0003
589 SKELETAL INJURY 3 0.0003
590 MULTI-ORGAN FAILURE 5 0.0003
591 PAPULE 2 0.0003
592 HYPERTENSION 60 0.0003
593 CARDIOGENIC SHOCK 4 0.0003
594 ADVERSE DRUG REACTION 25 0.0003
595 PRURITUS GENERALISED 6 0.0003
596 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
597 RASH PRURITIC 15 0.0003
598 FAECES SOFT 2 0.0003
599 FLUID OVERLOAD 4 0.0003
600 MELAENA 6 0.0003
601 ANAPHYLACTIC REACTION 15 0.0003
602 INFLAMMATION 14 0.0003
603 HEPATIC STEATOSIS 5 0.0003
604 RESPIRATORY DISORDER 8 0.0003
605 OXYGEN SATURATION DECREASED 15 0.0003
606 HEPATIC CIRRHOSIS 5 0.0003
607 INTESTINAL OBSTRUCTION 10 0.0003
608 IMPAIRED DRIVING ABILITY 3 0.0003
609 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
610 GASTRIC ULCER 5 0.0003
611 HEPATOCELLULAR CARCINOMA 2 0.0003
612 PROTEINURIA 5 0.0003
613 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
614 ATRIOVENTRICULAR BLOCK 2 0.0003
615 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
616 ELECTROLYTE IMBALANCE 3 0.0003
617 EYELID OEDEMA 3 0.0003
618 LUNG INFECTION 4 0.0003
619 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
620 PULMONARY HAEMORRHAGE 2 0.0003
621 BRAIN FOG 4 0.0003
622 ABDOMINAL PAIN 59 0.0003
623 RENAL CYST 2 0.0003
624 RESPIRATORY TRACT CONGESTION 4 0.0003
625 LOW BIRTH WEIGHT BABY 2 0.0003
626 FEELING COLD 7 0.0003
627 GENERAL PHYSICAL HEALTH DETERIORATION 29 0.0003
628 POLYNEUROPATHY 3 0.0003
629 EYE PAIN 14 0.0002
630 NO THERAPEUTIC RESPONSE 3 0.0002
631 INTENTIONAL DOSE OMISSION 7 0.0002
632 CONVULSION 14 0.0002
633 HYPERAESTHESIA 2 0.0002
634 PHARYNGITIS 3 0.0002
635 HEMIPLEGIA 2 0.0002
636 LIP SWELLING 8 0.0002
637 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
638 BRAIN OEDEMA 3 0.0002
639 DRUG INEFFECTIVE 312 0.0002
640 HYPOPHAGIA 6 0.0002
641 FACIAL PARALYSIS 2 0.0002
642 IMPAIRED WORK ABILITY 5 0.0002
643 MYOPATHY 2 0.0002
644 DIPLOPIA 6 0.0002
645 HYPONATRAEMIA 13 0.0002
646 RESPIRATORY TRACT INFECTION 6 0.0002
647 PLATELET COUNT INCREASED 3 0.0002
648 HOSPITALISATION 35 0.0002
649 IMMUNE SYSTEM DISORDER 3 0.0002
650 COLD SWEAT 4 0.0002
651 URTICARIA 38 0.0002
652 VISION BLURRED 31 0.0002
653 PLATELET COUNT DECREASED 24 0.0002
654 DYSPNOEA 127 0.0002
655 CARDIOTOXICITY 2 0.0002
656 GASTROOESOPHAGEAL REFLUX DISEASE 18 0.0002
657 QUALITY OF LIFE DECREASED 3 0.0002
658 RASH PAPULAR 5 0.0002
659 GOUT 4 0.0002
660 PNEUMONIA 72 0.0002
661 DYSPHONIA 13 0.0002
662 TOOTHACHE 4 0.0002
663 BONE DISORDER 4 0.0002
664 RETINAL DETACHMENT 2 0.0002
665 DYSGEUSIA 16 0.0002
666 SEPSIS 24 0.0002
667 ABDOMINAL DISCOMFORT 36 0.0002
668 FLANK PAIN 2 0.0002
669 SKIN REACTION 3 0.0002
670 BLOOD SODIUM DECREASED 4 0.0002
671 CHRONIC KIDNEY DISEASE 16 0.0002
672 COMA 10 0.0002
673 PARALYSIS 3 0.0002
674 LETHARGY 12 0.0002
675 PULMONARY FIBROSIS 4 0.0002
676 ACCIDENTAL UNDERDOSE 3 0.0002
677 HYPOKINESIA 3 0.0002
678 EAR PAIN 4 0.0002
679 APATHY 3 0.0002
680 DIARRHOEA 132 0.0002
681 CARDIOMYOPATHY 3 0.0002
682 HOSPICE CARE 2 0.0002
683 ASTHENIA 76 0.0002
684 INABILITY TO AFFORD MEDICATION 2 0.0002
685 HYPOTENSION 40 0.0002
686 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
687 HALLUCINATION 15 0.0002
688 HYPOAESTHESIA ORAL 3 0.0002
689 HYPOXIA 7 0.0002
690 PRODUCT ADMINISTRATION ERROR 4 0.0002
691 FEEDING DISORDER 4 0.0002
692 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
693 CEREBRAL HAEMORRHAGE 7 0.0002
694 RIB FRACTURE 4 0.0002
695 FATIGUE 151 0.0002
696 MUSCULOSKELETAL CHEST PAIN 3 0.0002
697 RASH GENERALISED 5 0.0002
698 C-REACTIVE PROTEIN INCREASED 7 0.0002
699 RHABDOMYOLYSIS 8 0.0002
700 BONE DENSITY DECREASED 6 0.0002
701 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
702 DEPRESSED MOOD 10 0.0002
703 RENAL PAIN 2 0.0002
704 PREMATURE DELIVERY 3 0.0002
705 RETCHING 4 0.0002
706 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
707 PRURITUS 72 0.0002
708 POOR QUALITY SLEEP 4 0.0002
709 PHARYNGITIS STREPTOCOCCAL 2 0.0002
710 PRODUCT DISPENSING ERROR 4 0.0002
711 DYSPEPSIA 18 0.0002
712 MANIA 3 0.0002
713 CARDIAC ARREST 15 0.0002
714 VENTRICULAR TACHYCARDIA 3 0.0002
715 TACHYCARDIA 16 0.0002
716 COAGULOPATHY 3 0.0002
717 FUNGAL INFECTION 6 0.0002
718 OCULAR DISCOMFORT 2 0.0002
719 MITRAL VALVE INCOMPETENCE 2 0.0002
720 PRODUCT AVAILABILITY ISSUE 4 0.0002
721 HAEMOGLOBIN DECREASED 18 0.0002
722 GASTRIC DISORDER 6 0.0002
723 HEADACHE 109 0.0002
724 HYPERSENSITIVITY 32 0.0002
725 NEUTROPHIL COUNT DECREASED 7 0.0002
726 PANCREATITIS 9 0.0002
727 NASAL CONGESTION 10 0.0002
728 SLEEP DISORDER 12 0.0002
729 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
730 WHEEZING 10 0.0002
731 BLOOD IRON DECREASED 2 0.0002
732 CHOLECYSTITIS 2 0.0002
733 RESTLESS LEGS SYNDROME 3 0.0002
734 DEHYDRATION 22 0.0002
735 BURSITIS 2 0.0002
736 NEURALGIA 4 0.0002
737 ACCIDENTAL OVERDOSE 6 0.0002
738 DISCOMFORT 10 0.0002
739 ENCEPHALOPATHY 4 0.0002
740 CONJUNCTIVITIS 3 0.0002
741 AGEUSIA 4 0.0002
742 DERMATITIS ALLERGIC 2 0.0002
743 FOOT FRACTURE 3 0.0002
744 HYPOTHYROIDISM 5 0.0002
745 DIZZINESS 78 0.0002
746 METABOLIC ACIDOSIS 5 0.0002
747 PULMONARY OEDEMA 7 0.0002
748 ABDOMINAL PAIN UPPER 32 0.0002
749 MALAISE 68 0.0002
750 SKIN ULCER 4 0.0002
751 CHOKING 3 0.0002
752 SKIN DISCOLOURATION 7 0.0002
753 PULMONARY CONGESTION 2 0.0002
754 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
755 HAEMATOCRIT DECREASED 3 0.0002
756 CHEST PAIN 28 0.0002
757 VISUAL ACUITY REDUCED 5 0.0002
758 VIRAL INFECTION 5 0.0002
759 FEAR 4 0.0001
760 ARRHYTHMIA 7 0.0001
761 VISUAL IMPAIRMENT 18 0.0001
762 CARPAL TUNNEL SYNDROME 2 0.0001
763 BLINDNESS UNILATERAL 2 0.0001
764 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
765 RED BLOOD CELL COUNT DECREASED 4 0.0001
766 HYPOACUSIS 6 0.0001
767 RHINORRHOEA 9 0.0001
768 PARAESTHESIA ORAL 2 0.0001
769 ANOSMIA 2 0.0001
770 FLUSHING 14 0.0001
771 DRUG EFFECT INCOMPLETE 5 0.0001
772 GASTROENTERITIS 2 0.0001
773 PULMONARY EMBOLISM 13 0.0001
774 PSYCHOTIC DISORDER 4 0.0001
775 ORAL PAIN 3 0.0001
776 SNEEZING 3 0.0001
777 HEPATIC FAILURE 4 0.0001
778 PRODUCT DOSE OMISSION ISSUE 39 0.0001
779 ARTHRALGIA 55 0.0001
780 UNEVALUABLE EVENT 10 0.0001
781 THERAPEUTIC RESPONSE DECREASED 8 0.0001
782 COLITIS 5 0.0001
783 DEVICE FAILURE 2 0.0001
784 OEDEMA PERIPHERAL 16 0.0001
785 PHARYNGEAL OEDEMA 2 0.0001
786 CONFUSIONAL STATE 21 0.0001
787 DELUSION 2 0.0001
788 ACUTE MYELOID LEUKAEMIA 2 0.0001
789 DYSPHAGIA 12 0.0001
790 RASH ERYTHEMATOUS 6 0.0001
791 MOVEMENT DISORDER 4 0.0001
792 MUSCLE TIGHTNESS 2 0.0001
793 PRESYNCOPE 3 0.0001
794 DYSKINESIA 5 0.0001
795 BACK DISORDER 2 0.0001
796 ANXIETY 35 0.0001
797 CEREBRAL INFARCTION 3 0.0001
798 MULTIPLE FRACTURES 2 0.0001
799 PNEUMONIA ASPIRATION 3 0.0001
800 URINARY RETENTION 4 0.0001
801 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
802 BONE PAIN 7 0.0001
803 CELLULITIS 6 0.0001
804 FACE OEDEMA 2 0.0001
805 UNRESPONSIVE TO STIMULI 3 0.0001
806 HAEMATOMA 3 0.0001
807 MENTAL DISORDER 5 0.0001
808 INSOMNIA 30 0.0001
809 GALLBLADDER DISORDER 2 0.0001
810 COLITIS ULCERATIVE 5 0.0001
811 THROAT IRRITATION 5 0.0001
812 DRUG EFFECT DECREASED 6 0.0001
813 FREQUENT BOWEL MOVEMENTS 3 0.0001
814 GASTROENTERITIS VIRAL 2 0.0001
815 INFECTION 16 0.0001
816 LIMB INJURY 3 0.0001
817 SYNCOPE 11 0.0001
818 PANIC ATTACK 4 0.0001
819 HAEMATOCHEZIA 6 0.0001
820 DYSURIA 4 0.0001
821 ADVERSE EVENT 10 0.0001
822 OROPHARYNGEAL PAIN 10 0.0001
823 BACK PAIN 25 0.0001
824 HYPOAESTHESIA 16 0.0001
825 ILLNESS 11 0.0001
826 PHOTOPHOBIA 2 0.0001
827 BLOOD URINE PRESENT 2 0.0001
828 HYPERSOMNIA 3 0.0001
829 SEIZURE 12 0.0001
830 HERNIA 2 0.0001
831 INTERSTITIAL LUNG DISEASE 5 0.0001
832 MYOCARDIAL INFARCTION 18 0.0001
833 HYPOGLYCAEMIA 5 0.0001
834 HAEMORRHOIDS 2 0.0001
835 ORAL HERPES 2 0.0001
836 ACUTE MYOCARDIAL INFARCTION 3 0.0001
837 ARTHRITIS 8 0.0001
838 PARAESTHESIA 16 0.0001
839 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
840 HEART RATE INCREASED 10 0.0001
841 EMOTIONAL DISTRESS 12 0.0001
842 CORONARY ARTERY DISEASE 3 0.0001
843 STOMATITIS 6 0.0001
844 DEVICE BREAKAGE 4 0.0001
845 WEIGHT INCREASED 22 0.0001
846 PAIN 60 0.0001
847 PRODUCT PREPARATION ERROR 2 0.0001
848 PERITONITIS 2 0.0001
849 MEMORY IMPAIRMENT 13 0.0001
850 BRADYCARDIA 5 0.0001
851 EATING DISORDER 2 0.0001
852 LOSS OF CONSCIOUSNESS 12 0.0001
853 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
854 DEPRESSION 21 0.0001
855 FAECES DISCOLOURED 2 0.0001
856 FEELING ABNORMAL 22 0.0001
857 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
858 PERIPHERAL SWELLING 14 0.0001
859 PRODUCT USE ISSUE 17 0.0001
860 FEBRILE NEUTROPENIA 6 0.0001
861 ANGIOEDEMA 4 0.0001
862 GAIT INABILITY 3 0.0001
863 EYE PRURITUS 3 0.0001
864 BLISTER 5 0.0001
865 FLATULENCE 5 0.0001
866 RHEUMATOID ARTHRITIS 10 0.0001
867 SINUSITIS 9 0.0001
868 ERYTHEMA 18 0.0001
869 CARDIAC FAILURE 7 0.0001
870 HERPES ZOSTER 5 0.0001
871 DRY MOUTH 7 0.0001
872 ABDOMINAL DISTENSION 9 0.0001
873 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
874 PALPITATIONS 10 0.0001
875 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
876 PRODUCT PRESCRIBING ERROR 2 0.0001
877 CATARACT 5 0.0001
878 BLOOD PRESSURE FLUCTUATION 2 0.0001
879 RESTLESSNESS 3 0.0001
880 FEELING HOT 5 0.0001
881 EPISTAXIS 6 0.0001
882 SOMNOLENCE 16 0.0001
883 CARDIOVASCULAR DISORDER 2 0.0001
884 BLOOD PRESSURE INCREASED 12 0.0001
885 TREMOR 13 0.0001
886 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
887 THERAPY CESSATION 4 0.0001
888 HYPERHIDROSIS 10 0.0001
889 ABORTION SPONTANEOUS 3 0.0001
890 THROMBOSIS 6 0.0001
891 EXTRA DOSE ADMINISTERED 3 0.0001
892 OEDEMA 4 0.0001
893 CONSTIPATION 16 0.0001
894 RESPIRATORY ARREST 2 0.0001
895 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
896 PROCEDURAL PAIN 2 0.0001
897 MEDICATION ERROR 4 0.0001
898 ANGINA PECTORIS 2 0.0001
899 BALANCE DISORDER 6 0.0001
900 DEVICE LEAKAGE 3 0.0001
901 LABORATORY TEST ABNORMAL 2 0.0001
902 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
903 IRRITABILITY 4 0.0001
904 BLOOD POTASSIUM DECREASED 2 0.0001
905 PREMATURE BABY 2 0.0001
906 HOT FLUSH 5 0.0001
907 JOINT SWELLING 8 0.0001
908 INCORRECT DOSE ADMINISTERED 15 0.0001
909 VERTIGO 4 0.0001
910 SKIN IRRITATION 3 0.0001
911 DRUG ADMINISTRATION ERROR 2 0.0001
912 NASOPHARYNGITIS 12 0.0001
913 COGNITIVE DISORDER 3 0.0001
914 HEAD INJURY 2 0.0001
915 MIGRAINE 6 0.0001
916 MULTIPLE SCLEROSIS 3 0.0001
917 GAIT DISTURBANCE 12 0.0001
918 ATRIAL FIBRILLATION 6 0.0001
919 DEEP VEIN THROMBOSIS 4 0.0001
920 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
921 SWELLING FACE 4 0.0001
922 CHOLELITHIASIS 2 0.0001
923 OSTEONECROSIS 2 0.0001
924 SKIN EXFOLIATION 5 0.0001
925 NIGHTMARE 2 0.0001
926 MUSCULOSKELETAL PAIN 3 0.0001
927 RASH MACULAR 2 0.0001
928 BURNING SENSATION 4 0.0001
929 SKIN BURNING SENSATION 4 0.0001
930 DEVICE ISSUE 5 0.0001
931 HYPERGLYCAEMIA 2 0.0001
932 UNDERDOSE 4 0.0001
933 EYE SWELLING 2 0.0001
934 NECK PAIN 3 0.0001
935 DYSARTHRIA 2 0.0001
936 ASTHMA 6 0.0001
937 DIABETES MELLITUS 4 0.0001
938 COVID-19 9 0.0001
939 PLASMA CELL MYELOMA 2 0.0001
940 SURGERY 3 0.0001
941 ABNORMAL BEHAVIOUR 2 0.0001
942 DISORIENTATION 2 0.0001
943 ILL-DEFINED DISORDER 3 0.0000
944 LUNG NEOPLASM MALIGNANT 2 0.0000
945 CARDIO-RESPIRATORY ARREST 2 0.0000
946 PAIN IN EXTREMITY 14 0.0000
947 OSTEOARTHRITIS 2 0.0000
948 PRODUCT STORAGE ERROR 4 0.0000
949 INTENTIONAL PRODUCT MISUSE 4 0.0000
950 BLOOD PRESSURE DECREASED 3 0.0000
951 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
952 INFLUENZA 5 0.0000
953 MUSCULAR WEAKNESS 5 0.0000
954 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
955 NEPHROLITHIASIS 2 0.0000
956 RENAL DISORDER 2 0.0000
957 BLOOD CHOLESTEROL INCREASED 2 0.0000
958 SWELLING 4 0.0000
959 OCULAR HYPERAEMIA 2 0.0000
960 MOBILITY DECREASED 3 0.0000
961 AGITATION 3 0.0000
962 ALOPECIA 8 0.0000
963 DEATH 35 0.0000
964 DRY EYE 2 0.0000
965 FALL 13 0.0000
966 DRUG DOSE OMISSION BY DEVICE 3 0.0000
967 PSORIASIS 5 0.0000
968 NERVOUSNESS 2 0.0000
969 HAEMORRHAGE 4 0.0000
970 DRY SKIN 5 0.0000
971 OVERDOSE 8 0.0000
972 EYE IRRITATION 2 0.0000
973 MUSCULOSKELETAL STIFFNESS 3 0.0000
974 CARDIAC DISORDER 3 0.0000
975 CONTUSION 3 0.0000
976 AMNESIA 2 0.0000
977 URINARY TRACT INFECTION 5 0.0000
978 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
979 MUSCLE SPASMS 5 0.0000
980 BRONCHITIS 2 0.0000
981 INJECTION SITE BRUISING 2 0.0000
982 CARDIAC FAILURE CONGESTIVE 2 0.0000
983 CEREBROVASCULAR ACCIDENT 4 0.0000
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
985 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
986 NO ADVERSE EVENT 3 0.0000
987 INJECTION SITE ERYTHEMA 2 0.0000
988 BLOOD GLUCOSE INCREASED 3 0.0000
989 PRODUCT QUALITY ISSUE 2 0.0000
990 INJECTION SITE PAIN 4 0.0000
991 DRUG DOSE OMISSION 2 0.0000